Clinical Trials Browser

Phase 1/2 × INDUSTRY × Radiation, Ionizing × Clear all

NCT02990416 2016-12-13

A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma

Phase 1/2 Unknown

Melanoma

NCT01888081 2016-11-23

A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma

Phase 1/2 Terminated

Melanoma